AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8005187 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release theophylline formulation 100 mg twice daily at 12 h intervals
Number of subjects: 7
Study 2689493 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective decontamination with polymyxin E, norfloxacin, amphotericin B and systemic antibiotic prophylaxis with trimethoprim
Number of subjects: 100
Study 2689493 — intervention group
Group type: COMPARATOR
Intervention: Control group (perioperative antimicrobial prophylaxis only)
Number of subjects: 100
Study 29058023 — intervention group
Group type: EXPERIMENTAL
Intervention: TKA with tourniquet (Group A, n=43)
Number of subjects: 86
Study 29058023 — intervention group
Group type: COMPARATOR
Intervention: TKA without tourniquet (Group B, n=43)
Number of subjects: 86
Study 26660591 — intervention group
Group type: EXPERIMENTAL
Intervention: In-office prophylaxis paste and toothpaste at home both containing 8% arginine and calcium carbonate (Pro‐Argin(™) Technology)
Number of subjects: 74
Study 26660591 — intervention group
Group type: COMPARATOR
Intervention: Fluoride‐free prophylaxis paste and fluoride toothpaste
Number of subjects: 74
Study 23786460 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide education intervention (2-hour duration)
Number of subjects: 74
Study 23786460 — intervention group
Group type: COMPARATOR
Intervention: Normal suicide care support (control group)
Number of subjects: 74
Study 22403308 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg/kg oral artesunate for three days followed by artemether-lumefantrine
Number of subjects: 44
Study 22403308 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg oral artesunate for three days followed by artemether-lumefantrine
Number of subjects: 44
Study 19056219 — intervention group
Group type: EXPERIMENTAL
Intervention: Furlong hydroxyapatite‐coated total hip arthroplasty
Number of subjects: 191
Study 19056219 — intervention group
Group type: COMPARATOR
Intervention: Charnley cemented total hip arthroplasty
Number of subjects: 191
Study 17554539 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum-tolerated doses (MTD) chemotherapy including 75 mg/m2 of cisplatin and 75 mg/m2 of docetaxel on day 1
Number of subjects: 40
Study 17554539 — intervention group
Group type: COMPARATOR
Intervention: Low-dose metronomic (LDM) chemotherapy consisting of cisplatin 25 mg/m2 and docetaxel 25 mg/m2 given on weeks 1, 2, and 3
Number of subjects: 40
Study 17056968 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin/Celecoxib combination (400 mg/150 mg 1 h before and 200 mg/150 mg 12 h after surgery)
Number of subjects: 80
Study 17056968 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg 1 h before and 200 mg 12 h after surgery)
Number of subjects: 80
Study 17056968 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (150 mg 1 h before and 150 mg 12 h after surgery)
Number of subjects: 80
Study 17056968 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin/Celecoxib combination
Number of subjects: 80
Study 17056968 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 h before and 12 h after surgery)
Number of subjects: 80
Study 12970206 — intervention group
Group type: EXPERIMENTAL
Intervention: Early revascularization (n=40, <or=1 month)
Number of subjects: 85
Study 12970206 — intervention group
Group type: COMPARATOR
Intervention: Late revascularization (n=45, >1 month)
Number of subjects: 85
Study 11384137 — intervention group
Group type: EXPERIMENTAL
Intervention: Left iliac fossa (LIF) puncture technique
Number of subjects: 93
Study 11384137 — intervention group
Group type: COMPARATOR
Intervention: Midline puncture technique
Number of subjects: 93
Study 11384137 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 93
Study 9232298 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposome-encapsulated tetracaine (LET) 5%
Number of subjects: 40
Study 9232298 — intervention group
Group type: COMPARATOR
Intervention: Eutectic mixture of local anaesthetics (EMLA)
Number of subjects: 40
Study 7950112 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffractive multifocal posterior chamber lens (IOL)
Number of subjects: 140
Study 3300672 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labor at 42 weeks gestation
Number of subjects: 0
Study 3300672 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 0
Study 2204472 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnSO4 (660 mg) per day
Number of subjects: 46
Study 2204472 — intervention group
Group type: COMPARATOR
Intervention: Medical starch (control)
Number of subjects: 46
Study 1095121 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafoxidine
Number of subjects: 98
Study 1095121 — intervention group
Group type: COMPARATOR
Intervention: Ethinyloestradiol
Number of subjects: 98
Study 30617588 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved cooking system (pellet and improved cookstove)
Number of subjects: 144
Study 30617588 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 144
Study 28009638 — intervention group
Group type: COMPARATOR
Intervention: Neutral head position
Number of subjects: 38
Study 28009638 — intervention group
Group type: EXPERIMENTAL
Intervention: Head rotated 45° to the right
Number of subjects: 38
Study 25911131 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents with VLBW infants
Number of subjects: 403
Study 25911131 — intervention group
Group type: COMPARATOR
Intervention: Parents with term infants
Number of subjects: 403
Study 24001382 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal sun protection education (two intensive instruction classes)
Number of subjects: 0
Study 24001382 — intervention group
Group type: COMPARATOR
Intervention: Control group (general advice about sun protection and broad-spectrum sunscreen)
Number of subjects: 0
Study 21881160 — intervention group
Group type: EXPERIMENTAL
Intervention: NL‐1000 piezoelectric pedometer at Level 3 (2.9 MET)
Number of subjects: 114
Study 21881160 — intervention group
Group type: EXPERIMENTAL
Intervention: NL‐1000 piezoelectric pedometer at Level 4 (3.6 MET)
Number of subjects: 114
Study 21881160 — intervention group
Group type: COMPARATOR
Intervention: Actical accelerometer
Number of subjects: 114
Study 20003405 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline intervention applied by occupational physicians for 6 months
Number of subjects: 20
Study 20003405 — intervention group
Group type: COMPARATOR
Intervention: Care as usual provided by control group
Number of subjects: 20
Study 17276217 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgical repair
Number of subjects: 76
Study 17276217 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment with a fixed sling for 1 week followed by rehabilitation
Number of subjects: 76
Study 17276217 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 76
Study 15507072 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesic use (any)
Number of subjects: 1801
Study 15507072 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid analgesic use
Number of subjects: 1801
Study 15507072 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional impairment from pain
Number of subjects: 1801
Study 15507072 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis or treatment for chronic pain
Number of subjects: 1801
Study 15507072 — intervention group
Group type: EXPERIMENTAL
Intervention: Differences in analgesic use across organizations
Number of subjects: 1801
Study 11411655 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral needle ablation (TUNA)
Number of subjects: 27
Study 11411655 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy (urethrocystoscopy)
Number of subjects: 27
Study 10710819 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate loading (CHO1)
Number of subjects: 4
Study 10710819 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate loading (CHO2)
Number of subjects: 4
Study 10710819 — intervention group
Group type: COMPARATOR
Intervention: No carbohydrate loading (C1)
Number of subjects: 4
Study 10710819 — intervention group
Group type: COMPARATOR
Intervention: No carbohydrate loading (C2)
Number of subjects: 4
Study 8142205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cyclophosphamide
Number of subjects: 13
Study 8142205 — intervention group
Group type: COMPARATOR
Intervention: Oral cyclophosphamide
Number of subjects: 13
Study 2843305 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg)
Number of subjects: 11
Study 2843305 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (10 mg)
Number of subjects: 11
Study 2843305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 30574865 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine in extensive metabolizers (EMs)
Number of subjects: 70
Study 30574865 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine in poor metabolizers (PMs)
Number of subjects: 70
Study 30574865 — intervention group
Group type: COMPARATOR
Intervention: Conventional dataset
Number of subjects: 70
Study 30574865 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-based stratified groups
Number of subjects: 70
Study 27744739 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-loss program plus exercise (WL + E group, n=28)
Number of subjects: 55
Study 27744739 — intervention group
Group type: COMPARATOR
Intervention: Weight-loss program plus sham (WL + S group, n=27)
Number of subjects: 55
Study 26258567 — intervention group
Group type: EXPERIMENTAL
Intervention: Model C - nurse or lay counselors offered and provided HTC before clinical consultation
Number of subjects: 79910
Study 26258567 — intervention group
Group type: EXPERIMENTAL
Intervention: Model A - health care providers referred eligible patients to on-site HTC after clinical consultation
Number of subjects: 79910
Study 26258567 — intervention group
Group type: EXPERIMENTAL
Intervention: Model B - health care providers offered and provided HTC during clinical consultation
Number of subjects: 79910
Study 26258567 — intervention group
Group type: COMPARATOR
Intervention: All models combined
Number of subjects: 79910
Study 23182987 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Number of subjects: 0
Study 23182987 — intervention group
Group type: COMPARATOR
Intervention: Stanford V
Number of subjects: 0
Study 23182987 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD
Number of subjects: 0
Study 20850852 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrapping of the pedicle omental flap around the esophagogastric anastomosis (Group A)
Number of subjects: 255
Study 20850852 — intervention group
Group type: COMPARATOR
Intervention: Stapled technique for esophagogastrectomy (Group B)
Number of subjects: 255
Study 18155445 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive topiramate (TPM)
Number of subjects: 67
Study 18155445 — intervention group
Group type: COMPARATOR
Intervention: Adjunctive lamotrigine (LTG)
Number of subjects: 67
Study 17063975 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin (50 IU anti‐Xa/kg, single intravenous bolus)
Number of subjects: 24
Study 12668365 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day
Number of subjects: 566
Study 12668365 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 40 mg/day
Number of subjects: 566
Study 12668365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 566
Study 11035679 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.68 microm saline solution droplets inhaled for 30 s at 12 L/min
Number of subjects: 9
Study 11035679 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.68 microm saline solution droplets inhaled for 30 s at 31 L/min
Number of subjects: 9
Study 11035679 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.01 microm saline solution droplets inhaled for 30 s at 18 L/min
Number of subjects: 9
Study 11035679 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.01 microm saline solution droplets inhaled for 30 s at 38 L/min
Number of subjects: 9
Study 9220416 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT)
Number of subjects: 63
Study 9220416 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 63
Study 1621545 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavernous E1 prostaglandin E1 (E1‐PG) injection
Number of subjects: 70
Study 1621545 — intervention group
Group type: COMPARATOR
Intervention: Papaverine
Number of subjects: 70
Study 6326932 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy and radiotherapy (40 Gy, one fraction a day over 20 days)
Number of subjects: 371
Study 6326932 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 371
Study 30560750 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive data
Number of subjects: 46
Study 30560750 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiology, structural MRI, diffusion tensor imaging
Number of subjects: 46
Study 30560750 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal analyses with cognition plus any combination of one or more of the remaining three modalities
Number of subjects: 46
Study 30560750 — intervention group
Group type: EXPERIMENTAL
Intervention: None of the modalities
Number of subjects: 46
Study 29779806 — intervention group
Group type: EXPERIMENTAL
Intervention: Common bean BRS Estilo (Group CB)
Number of subjects: 29
Study 29779806 — intervention group
Group type: EXPERIMENTAL
Intervention: Common bean BRS Pontal (Group TBB)
Number of subjects: 29
Study 26680217 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary leaflet summarising the gist of the key information (Trial 1)
Number of subjects: 747856
Study 26680217 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary narrative leaflet describing people's stories (Trial 2)
Number of subjects: 747856
Study 26680217 — intervention group
Group type: EXPERIMENTAL
Intervention: General practice endorsement of the programme on the invitation letter (Trial 3)
Number of subjects: 747856
Study 26680217 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced reminder letter with a banner reiterating the screening offer (Trial 4)
Number of subjects: 747856
Study 24225338 — intervention group
Group type: EXPERIMENTAL
Intervention: miglitol (M-group; n=52)
Number of subjects: 104
Study 24225338 — intervention group
Group type: COMPARATOR
Intervention: nateglinide (N-group; n=52)
Number of subjects: 104
Study 22506822 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally relevant web‐MI intervention (web‐MI) in English and Spanish
Number of subjects: 27
Study 20388813 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized dental simulator (CDS) training (n=39)
Number of subjects: 75
Study 20388813 — intervention group
Group type: COMPARATOR
Intervention: Traditional preclinical dental training alone (n=36)
Number of subjects: 75
Study 18758204 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 10
Study 15940178 — intervention group
Group type: EXPERIMENTAL
Intervention: CO(2) laser application for sanation of trophic venous ulcers
Number of subjects: 94
Study 15940178 — intervention group
Group type: EXPERIMENTAL
Intervention: Early correction of upper vertical venous‐venous reflux
Number of subjects: 94
Study 15940178 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto‐venous plastic reconstruction
Number of subjects: 94
Study 12564815 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillomandibular fixation (54 patients)
Number of subjects: 103
Study 12564815 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium miniplate fixation (49 patients)
Number of subjects: 103
Study 12564815 — intervention group
Group type: COMPARATOR
Intervention: Control group (44 healthy individuals)
Number of subjects: 103
Study 10364660 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasound (CDUS) measuring renal resistive index (RI)
Number of subjects: 46
Study 10364660 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasound (CDUS)
Number of subjects: 46
Study 8834816 — intervention group
Group type: EXPERIMENTAL
Intervention: Praneem Vilci (PV)
Number of subjects: 18
Study 8834816 — intervention group
Group type: COMPARATOR
Intervention: HSD-hCG vaccine
Number of subjects: 18
Study 2255169 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-927
Number of subjects: 24
Study 2255169 — intervention group
Group type: COMPARATOR
Intervention: Betaxolol
Number of subjects: 24
Study 435953 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete bed rest
Number of subjects: 0
Study 435953 — intervention group
Group type: COMPARATOR
Intervention: Full mobilisation with the affected knee in a firm splint
Number of subjects: 0
Study 31644339 — intervention group
Group type: EXPERIMENTAL
Intervention: PO (unfed) misoprostol (5 μg/kg)
Number of subjects: 8
Study 31644339 — intervention group
Group type: COMPARATOR
Intervention: PO (fed) misoprostol (5 μg/kg)
Number of subjects: 8
Study 31644339 — intervention group
Group type: EXPERIMENTAL
Intervention: PR misoprostol (5 μg/kg)
Number of subjects: 8
Study 29357594 — intervention group
Group type: EXPERIMENTAL
Intervention: LAS41008 (dimethyl fumarate)
Number of subjects: 0
Study 29357594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25537177 — intervention group
Group type: EXPERIMENTAL
Intervention: OLM 80
Number of subjects: 69
Study 25537177 — intervention group
Group type: EXPERIMENTAL
Intervention: OLM 20
Number of subjects: 69
Study 25537177 — intervention group
Group type: EXPERIMENTAL
Intervention: AML 5
Number of subjects: 69
Study 23424263 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture in combination with conventional therapy
Number of subjects: 852
Study 20850849 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibacterial soap
Number of subjects: 197
Study 20850849 — intervention group
Group type: COMPARATOR
Intervention: Plain soap
Number of subjects: 197
Study 18315424 — intervention group
Group type: EXPERIMENTAL
Intervention: Free gingival graft (FGG)
Number of subjects: 23
Study 18315424 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (CTG)
Number of subjects: 23
Study 18315424 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CTG and FGG
Number of subjects: 23
Study 17048209 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg/day (3 mg/m2 in children)
Number of subjects: 378
Study 17048209 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg/day (175 mg/m2 in children)
Number of subjects: 378
Study 17048209 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 378
Study 12865034 — intervention group
Group type: EXPERIMENTAL
Intervention: Using 5 items in assessment
Number of subjects: 950
Study 12865034 — intervention group
Group type: EXPERIMENTAL
Intervention: Using 50 items in assessment
Number of subjects: 950
Study 12865034 — intervention group
Group type: EXPERIMENTAL
Intervention: Using at least 20 items in assessment
Number of subjects: 950
Study 10938491 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education intervention
Number of subjects: 108
Study 1444772 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric‐Eccentric Slow (MS)
Number of subjects: 25
Study 1444772 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric‐Eccentric Fast (MF)
Number of subjects: 25
Study 1444772 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric Slow (CS)
Number of subjects: 25
Study 1444772 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric Fast (CF)
Number of subjects: 25
Study 1444772 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 25
Study 3912970 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acyclovir
Number of subjects: 35
Study 3912970 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 30825341 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium brush
Number of subjects: 30
Study 30825341 — intervention group
Group type: COMPARATOR
Intervention: Control group (3% H2O2 and plastic ultrasonic scalers)
Number of subjects: 30
Study 29102957 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise dose increase of febuxostat from 10 to 40 mg/day
Number of subjects: 241
Study 29102957 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg/day plus fixed-dose febuxostat 40 mg/day
Number of subjects: 241
Study 29102957 — intervention group
Group type: COMPARATOR
Intervention: Fixed-dose febuxostat 40 mg/day
Number of subjects: 241
Study 27824913 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-epileptic drugs (AEDs)
Number of subjects: 41
Study 27824913 — intervention group
Group type: COMPARATOR
Intervention: Trial AED compared with positive controls
Number of subjects: 41
Study 27824913 — intervention group
Group type: EXPERIMENTAL
Intervention: Delays in AED administration from seizure onset
Number of subjects: 41
Study 27824913 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs in neonates treated with hypothermia
Number of subjects: 41
Study 25458644 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (titrated from 15 to 45 mg/d)
Number of subjects: 3876
Study 25458644 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 3876
Study 21979312 — intervention group
Group type: EXPERIMENTAL
Intervention: HVLA thrust manipulation
Number of subjects: 107
Study 21979312 — intervention group
Group type: COMPARATOR
Intervention: Nonthrust mobilization
Number of subjects: 107
Study 20510973 — intervention group
Group type: EXPERIMENTAL
Intervention: Telecommunication-based Tai Chi exercise (Tele-ex)
Number of subjects: 64
Study 20510973 — intervention group
Group type: EXPERIMENTAL
Intervention: Community center-based Tai Chi exercise (Comm-ex)
Number of subjects: 64
Study 20510973 — intervention group
Group type: COMPARATOR
Intervention: Home video-based Tai Chi exercise (Home-ex)
Number of subjects: 64
Study 18833867 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide (0.01 mcg/kg/min) in addition to maximal standard therapy
Number of subjects: 34
Study 18833867 — intervention group
Group type: COMPARATOR
Intervention: Maximal standard therapy
Number of subjects: 34
Study 16173377 — intervention group
Group type: EXPERIMENTAL
Intervention: No Conflict condition
Number of subjects: 44
Study 16173377 — intervention group
Group type: COMPARATOR
Intervention: Conflict condition
Number of subjects: 44
Study 12185153 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with lofepramine 70 mg and L-phenylalanine 500 mg twice daily, plus vitamin B-12 1 mg intramuscularly weekly.
Number of subjects: 138